Loading clinical trials...

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain | Clinical Trials | Clareo Health

COMPLETED

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study

NCT00195377•Wyeth is now a wholly owned subsidiary of Pfizer

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the safety of etanercept in patients with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) or psoriatic arthritis (PsA) in Spain

Eligibility

Age

4 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•RA or PsA in whom DMARDs/antiTNF antibodies/anti IL1 has been insufficient or inappropriate
•Children from 4 to 17 years old with JIA polyarticular

Exclusion Criteria

•Clinically significant abnormal screening lab values
•Patients who are planning to undergo elective surgery during the study period.
•Other current autoimmune connective tissue diseases

Locations (1)

Madrid, Madrid, Spain

Key Dates

Start Date

April 1, 2003

Primary Completion Date

April 1, 2006

Completion Date

April 1, 2006

Last Updated

June 18, 2009

Enrollment

1,000

Estimated participants

Conditions

Arthritis, PsoriaticArthritis, Rheumatoid

Interventions

Etanercept

DRUG

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

NCT07017686

Arthritis, Rheumatoid

View study

RECRUITINGPHASE1

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

NCT06522035

Arthritis, Psoriatic

View study

RECRUITING

Chronic Pain in Rheumatoid Arthritis

NCT05038553

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

Inclusion Criteria

Exclusion Criteria

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Chronic Pain in Rheumatoid Arthritis

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis